THE WOODLANDS, Tex.--Lexi con Genetics here has announced a functional genomics research agreement with ZymoGe netics, the US healthcare research affiliate of the Danish company Novo Nordisk. The multiyear deal grants both ZymoGenetics and Novo Nordisk nonexclusive access to Lexicon's OmniBank gene sequence database, which corresponds to a library of novel mutant mouse embryonic stem cell clones, as well as allowing for the rapid generation of novel mouse mutants for use in ZymoGenetics' programs in gene functional analysis and drug discovery.